Behavioural and neural effects of diazepam on a rule-guided response selection task

Neuroscience Research

Volumn 70, Issue 3, 2011, Pages 260-268

  Munoz Torres Z ^a   Armony, J L ^a,b   Trejo Martinez D ^c   Conde, R ^c   Corsi Cabrera, M ^a  

^a UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^b DOUGLAS MENTAL HEALTH UNIVERSITY INSTITUTE   (Canada)

^c HOSPITAL ÁNGELES DEL PEDREGAL   (Mexico)

Author keywords

Benzodiazepine; Cognition; Diazepam; Drug; FMRI; Human; Rule guided behaviour

Indexed keywords

DIAZEPAM;

ACCURACY; ADULT; ANTERIOR CINGULATE; ARTICLE; BEHAVIOR; BRAIN MAPPING; BRAIN REGION; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG EFFECT; HUMAN; HUMAN EXPERIMENT; MALE; MIDDLE FRONTAL GYRUS; MOTOR PERFORMANCE; NORMAL HUMAN; OCCIPITAL CORTEX; PARIETAL CORTEX; PRIORITY JOURNAL; REACTION TIME; RETROSPLENIAL CORTEX; TASK PERFORMANCE; TEMPORAL LOBE;

ADULT; CEREBRAL CORTEX; COGNITION; DECISION MAKING; DIAZEPAM; FEMALE; HUMANS; HYPNOTICS AND SEDATIVES; MAGNETIC RESONANCE IMAGING; MALE; YOUNG ADULT;

EID: 79957581953     PISSN: 01680102     EISSN: 18728111     Source Type: Journal    
DOI: 10.1016/j.neures.2011.03.009     Document Type: Article

References (51)

1. Abi-Dargham A., Gandelman M., Zoghbi S.S., Laruelle M., Baldwin R.M., Randall P., Zea-Ponce Y., Charney D.S., Hoffer P.B., Innis R.B. Reproducibility of SPECT measurement of benzodiazepine receptors in human brain with iodine-123-iomazenil. J. Nucl. Med. 1995, 36:167-175.
2. Aeschbach D., Cajochen C., Tobler I., Dijk D.J., Borbély A.A. Sleep in a sitting position: effect of triazolam on sleep stages and EEG power spectra. Psychopharmacology (Berl.) 1994, 114:209-214.
3. Annett M. The binomial distribution of right, mixed and left handedness. Q. J. Exp. Psychol. 1967, 19:327-333.
4. Bellebaum C., Daum I. Mechanisms of cerebellar involvement in associative learning. Cortex 2011, 47:128-136.
5. Berchou R., Block R.I. Use of computerized psychomotor testing in determining CNS effects of drugs. Percept. Motor Skills 1983, 57:691-700.
6. Botvinick M.M. Conflict monitoring and decision making: reconciling two perspectives on anterior cingulate function. Cogn. Affect. Behav. Neurosci. 2007, 7:356-366.
7. Buffett-Jerrott S.E., Stewart S.H. Cognitive and sedative effects of benzodiazepine use. Curr. Pharm. Des. 2002, 8:45-58.
8. Bunge S.A. How we use rules to select actions: a review of evidence from cognitive neuroscience. Cogn. Affect. Behav. Neurosci. 2004, 4:564-579.
9. Bunge S.A., Kahn I., Wallis J.D., Miller E.K., Wagner A.D. Neural circuits subserving the retrieval and maintenance of abstract rules. J. Neurophysiol. 2003, 90:3419-3428.
10. Bunge S.A., Wallis J.D., Parker A., Brass M., Crone E.A., Hoshi E., Sakai K. Neural circuitry underlying rule use in humans and nonhuman primates. J. Neurosci. 2005, 25:10347-10350.
11. Christoff K., Keramatian K., Gordon A.M., Smith R., Mädler B. Prefrontal organization of cognitive control according to levels of abstraction. Brain Res. 2009, 1286:94-105.
12. Corbetta M., Kincade J.M., Ollinger J.M., McAvoy M.P., Shulman G.L. Voluntary orienting is dissociated from target detection in human posterior parietal cortex. Nat. Neurosci. 2000, 3:292-297.
13. Corbetta M., Shulman G.L. Control of goal-directed and stimulus-driven attention in the brain. Nat. Rev. Neurosci. 2002, 3:201-215.
14. Coull J.T., Frith C.D., Dolan R.J. Dissociating neuromodulatory effects of diazepam on episodic memory encoding and executive function. Psychopharmacology (Berl.) 1999, 145:213-222.
15. Coull J.T., Sahakian B.J., Middleton H.C., Young A.H., Park S.B., McShane R.H., Cowen P.J., Robbins T.W. Differential effects of clonidine, haloperidol, diazepam and tryptophan depletion on focused attention and attentional search. Psychopharmacology (Berl.) 1995, 121:222-230.
16. Curran H.V. Benzodiazepines, memory, and mood: a review. Psychopharmacology (Berl.) 1991, 105:1-8.
17. Curran H.V., Pooviboonsuk P., Dalton J.A., Lader M.H. Differentiating the effects of centrally acting drugs on arousal and memory: an event-related potential study of scopolamine, lorazepam and diphenhydramine. Psychopharmacology (Berl.) 1998, 135:27-36.
18. Deakin J.B., Aitken M.R., Dowson J.H., Robbins T.W., Sahakian B.J. Diazepam produces disinhibitory cognitive effects in male volunteers. Psychopharmacology (Berl.) 2004, 173:88-97.
19. Donohue S.E., Wendelken C., Crone E.A., Bunge S.A. Retrieving rules for behaviour from long-term memory. Neuroimage 2005, 26:1140-1149.
20. Evans A.C., Kamber M., Collins D.L., Macdonald D. An MRI-based probabilistic atlas of neuroanatomy. Magnetic Resonance Scanning and Epilepsy 1994, 263-274. Plenum, New York. S. Shorvon, D. Fish, F. Andermann, G.M. Bydder, H. Stefan (Eds.).
21. Finelli L.A., Landolt H.P., Buck A., Roth C., Berthold T., Borbély A.A., Achermann P. Functional neuroanatomy of human sleep states after zolpidem and placebo: a H215O-PET study. J. Sleep Res. 2000, 9:161-173.
22. Fluck E., Fernandes C., File S.E. Are lorazepam-induced deficits in attention similar to those resulting from aging?. J. Clin. Psychopharmacol. 2001, 21:126-130.
23. Friedman H., Ochs H.R., Greenblatt D.J., Shader R.I. Tissue distribution of diazepam and its metabolite desmethyldiazepam: a human autopsy study. J. Clin. Pharmacol. 1985, 25:613-615.
24. Friston K.J., Holmes A.P., Worsley K.J., Poline J.B., Frith C., Frackowiak R.S.J. Statistical parametric maps in functional imaging: a general linear approach. Hum. Brain Mapp. 1995, 2:189-210.
25. Fuster J. The Prefrontal Cortex 2008, Elsevier, USA, pp. 424.
26. Goldberg E., Podell K., Lovell M. Lateralization of frontal lobe functions and cognitive novelty. J. Neuropsychiat. Clin. Neurosci. 1994, 6:371-378.
27. Hall S.D., Barnes G.R., Furlong P.L., Seri S., Hillebrand A. Neuronal network pharmacodynamics of GABAergic modulation in the human cortex determined using pharmaco-magnetoencephalography. Hum. Brain Mapp. 2010, 31:581-594.
28. Huettel S.A., McCarthy G. What is odd in the oddball task? Prefrontal cortex is activated by dynamic changes in response strategy. Neuropsychologia 2004, 42:379-386.
29. Jensen O., Goel P., Kopell N., Pohja M., Hari R., Ermentrout B. On the human sensorimotor-cortex beta rhythm: sources and modeling. Neuroimage 2005, 26:347-355.
30. Krause B.J., Horwitz B., Taylor J.G., Schmidt D., Mottaghy F.M., Herzog H., Halsband U., Müller-Gärtner H. Network analysis in episodic encoding and retrieval of word-pair associates: a PET study. Eur. J. Neurosci. 1999, 11:3293-3301.
31. Majewska M.D., Harrison N.L., Schwartz R.D., Barker J.L., Paul S.M. Steroid hormone metabolites are barbiturate-like modulators of the GABA receptor. Science 1986, 232:1004-1007.
32. Masson G.S., Mestre D.R., Martineau F., Soubrouillard C., Brefel C., Rascol O., Blin O. Lorazepam-induced modifications of saccadic and smooth-pursuit eye movements in humans: attentional and motor factors. Behav. Brain Res. 2000, 108:169-180.
33. Millet P., Graf C., Moulin M., Ibáñez V. SPECT quantification of benzodiazepine receptor concentration using a dual-ligand approach. J. Nucl. Med. 2006, 47:783-792.
34. Mintzer M.Z., Griffiths R.R. Selective effects of zolpidem on human memory functions. J. Psychopharmacol. 1999, 13:18-31.
35. Mintzer M.Z., Griffiths R.R., Contoreggi C., Kimes A.S., London E.D., Ernst M. Effects of triazolam on brain activity during episodic memory encoding: a PET study. Neuropsychopharmacology 2001, 25:744-756.
36. Mohler H., Okada T. Benzodiazepine receptor: demonstration in the central nervous system. Science 1977, 198:849-851.
37. Nutt D.J., Malizia A.L. New insights into the role of the GABA(A)-benzodiazepine receptor in psychiatric disorder. Br. J. Psychiatry 2001, 179:390-396.
38. O'Neil E.B., Cate A.D., Köhler S. Perirhinal cortex contributes to accuracy in recognition memory and perceptual discriminations. J. Neurosci. 2009, 29:8329-8334.
39. Petersen S.E., Corbetta M., Miezin F.M., Shulman G.L. PET studies of parietal involvement in spatial attention: comparison of different task types. Can. J. Exp. Psychol. 1994, 48:319-338.
40. Petrides M., Pandya D. Association pathways of the prefrontal cortex and functional observations. Principles of Frontal Lobe Function 2002, 31-50. Oxford University Press, USA. D. Stuss, R. Knight (Eds.).
41. Pompéia S., Manzano G.M., Pradella-Hallinan M., Bueno O.F. Effects of lorazepam on deductive reasoning. Psychopharmacology (Berl.) 2007, 194:527-536.
42. Reinsel R.A., Veselis R.A., Dnistrian A.M., Feshchenko V.A., Beattie B.J., Duff M.R. Midazolam decreases cerebral blood flow in the left prefrontal cortex in a dose-dependent fashion. Int. J. Neuropsychopharmacol. 2000, 3(2):117-127.
43. Romano-Torres M., Borja-Lascurain E., Chao-Rebolledo C., del-Río-Portilla Y., Corsi-Cabrera M. Effect of diazepam on EEG power and coherent activity: sex differences. Psychoneuroendocrinology 2002, 27. 821-233.
44. Smith S.S., Shen H., Gong Q.H., Zhou X. Neurosteroid regulation of GABA(A) receptors: focus on the alpha4 and delta subunits. Pharmacol. Ther. 2007, 116:58-76.
45. Squires R.F., Braestrup C. Benzodiazepine receptors in rat brain. Nature 1977, 266:732-734.
46. Stuss D., Knight R. Principles of Frontal Lobe Function 2002, Oxford University Press, USA, pp. 640.
47. Talairach J., Tournoux P. Co-planar Stereotaxic Atlas of the Human Brain: 3-Dimensional Proportional System: An Approach to Cerebral Imaging 1988, Thieme, New York, pp. 122.
48. Tanaka K. Columns for complex visual object features in the inferotemporal cortex: clustering of cells with similar but slightly different stimulus selectivities. Cereb. Cortex 2003, 13:90-99.
49. Veselis R.A., Reinsel R.A., Beattie B.J., Mawlawi O.R., Feshchenko V.A., DiResta G.R., Larson S.M., Blasberg R.G. Midazolam changes cerebral blood flow in discrete brain regions: an H2(15)O positron emission tomography study. Anesthesiology 1997, 87:1106-1117.
50. Wang G.J., Volkow N.D., Levy A.V., Felder C.A., Fowler J.S., Pappas N.R., Hitzemann R.J., Wong C.T. Measuring reproducibility of regional brain metabolic responses to lorazepam using statistical parametric maps. J. Nucl. Med. 1999, 40:715-720.
51. Woods J.H., Katz J.L., Winger G. Benzodiazepines: use, abuse, and consequences. Pharmacol. Rev. 1992, 44:151-347.